S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
From -60% Account to Doubling His Money? (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Get MarketBeat All Access Free for 30 Days (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
From -60% Account to Doubling His Money? (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Get MarketBeat All Access Free for 30 Days (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
From -60% Account to Doubling His Money? (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Get MarketBeat All Access Free for 30 Days (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Opera Stock: The Fast-Rising Star of AI-Driven Web Experiences
From -60% Account to Doubling His Money? (Ad)
What Should Investors Make of These 3 Dividend Cuts?
Symbotic AI Robots Disrupt Warehouse Industry, Stock Price Soars
Get MarketBeat All Access Free for 30 Days (Ad)
CrowdStrike: Another Tech Stock to Buy on the Dip 
Broadcom Stock Pulls into the Buy Zone: Analysts Raise Targets
Wall Street Veteran: "A New Wave of Crashes Will Rock US Stocks" (Ad)
Salesforce: Time to Snap it Up as the Market Buys the Dip?
Zscaler: Analysts Raise the Bar for the AI Cloud Security Company
NYSE:MED

Medifast (MED) Stock Forecast, Price & News

$83.68
+4.40 (+5.55%)
(As of 06/2/2023 ET)
Compare
Today's Range
$80.30
$83.78
50-Day Range
$78.69
$103.67
52-Week Range
$77.67
$192.44
Volume
193,922 shs
Average Volume
209,595 shs
Market Capitalization
$911.02 million
P/E Ratio
6.55
Dividend Yield
7.89%
Price Target
$110.50

Medifast MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
32.1% Upside
$110.50 Price Target
Short Interest
Healthy
15.33% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-4.12
Upright™ Environmental Score
News Sentiment
0.38mentions of Medifast in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$239,096 Sold Last Quarter
Proj. Earnings Growth
10.16%
From $8.86 to $9.76 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.78 out of 5 stars

Consumer Staples Sector

15th out of 140 stocks

Miscellaneous Food Preparations & Kindred Products Industry

1st out of 5 stocks


MED stock logo

About Medifast (NYSE:MED) Stock

Medifast, Inc. engages in the provision of healthy living products and programs. It offers the OPTAVIA brand, a lifestyle solution centered on developing new healthy habits through smaller, foundational changes called micro-habits. The firm's product line includes bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The company was founded by William Vitale in 1981 and is headquartered in Baltimore, MD.

Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

MED Stock News Headlines

NOTICE: Your retirement is in immediate danger
Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>
Medifast (NYSE:MED) Stock Rating Upgraded by StockNews.com
NOTICE: Your retirement is in immediate danger
Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>
Medifast (NYSE:MED) Now Covered by StockNews.com
Medifast (NYSE:MED) Downgraded by StockNews.com to "Hold"
Q1 2023 Medifast Inc Earnings Call
Medifast (NYSE:MED) Raised to "Buy" at StockNews.com
Medifast (MED) to Release Quarterly Earnings on Monday
Is Medifast, Inc. (NYSE:MED) Potentially Undervalued?
See More Headlines

MED Price History

MED Company Calendar

Ex-Dividend for 5/9 Dividend
3/27/2023
Last Earnings
5/01/2023
Dividend Payable
5/09/2023
Today
6/02/2023
Next Earnings (Estimated)
8/02/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous food preparations & kindred products
Sub-Industry
Personal Products
CUSIP
58470H10
Employees
984
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$110.50
High Stock Price Forecast
$150.00
Low Stock Price Forecast
$71.00
Forecasted Upside/Downside
+32.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$143.57 million
Pretax Margin
11.92%

Debt

Sales & Book Value

Annual Sales
$1.53 billion
Cash Flow
$16.97 per share
Book Value
$15.70 per share

Miscellaneous

Free Float
10,637,000
Market Cap
$911.02 million
Optionable
Optionable
Beta
1.24

Key Executives

  • Daniel R. ChardDaniel R. Chard
    Executive Chairman & Chief Executive Officer
  • Anthony Tyree
    Chief Business Operations Officer
  • James P. Maloney
    Chief Financial Officer
  • Nicholas M. Johnson
    Chief Field Operations Officer
  • Jonathan B. MacKenzie
    Chief Accounting Officer & Vice President-Finance













MED Stock - Frequently Asked Questions

Should I buy or sell Medifast stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MED, but not buy additional shares or sell existing shares.
View MED analyst ratings
or view top-rated stocks.

What is Medifast's stock price forecast for 2023?

2 Wall Street research analysts have issued 1-year price objectives for Medifast's shares. Their MED share price forecasts range from $71.00 to $150.00. On average, they predict the company's share price to reach $110.50 in the next year. This suggests a possible upside of 32.1% from the stock's current price.
View analysts price targets for MED
or view top-rated stocks among Wall Street analysts.

How have MED shares performed in 2023?

Medifast's stock was trading at $115.35 on January 1st, 2023. Since then, MED stock has decreased by 27.5% and is now trading at $83.68.
View the best growth stocks for 2023 here
.

Are investors shorting Medifast?

Medifast saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 1,730,000 shares, an increase of 9.5% from the April 15th total of 1,580,000 shares. Based on an average daily volume of 238,500 shares, the short-interest ratio is currently 7.3 days. Currently, 16.3% of the company's shares are short sold.
View Medifast's Short Interest
.

When is Medifast's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our MED earnings forecast
.

How were Medifast's earnings last quarter?

Medifast, Inc. (NYSE:MED) issued its earnings results on Monday, May, 1st. The specialty retailer reported $3.67 earnings per share for the quarter, topping the consensus estimate of $2.40 by $1.27. The specialty retailer had revenue of $349 million for the quarter, compared to the consensus estimate of $319.50 million. Medifast had a trailing twelve-month return on equity of 106.70% and a net margin of 9.27%. The company's revenue was down 16.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $3.59 EPS.

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast declared a quarterly dividend on Thursday, March 16th. Stockholders of record on Tuesday, March 28th will be given a dividend of $1.65 per share on Tuesday, May 9th. This represents a $6.60 annualized dividend and a yield of 7.89%. The ex-dividend date of this dividend is Monday, March 27th. This is an increase from the stock's previous quarterly dividend of $1.64.
Read our dividend analysis for MED
.

Is Medifast a good dividend stock?

Medifast (NYSE:MED) pays an annual dividend of $6.60 per share and currently has a dividend yield of 8.04%. MED has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 51.68%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, MED will have a dividend payout ratio of 67.62% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MED.

What guidance has Medifast issued on next quarter's earnings?

Medifast issued an update on its second quarter earnings guidance on Monday, May, 1st. The company provided earnings per share (EPS) guidance of $1.32-$1.44 for the period, compared to the consensus earnings per share estimate of $2.82. The company issued revenue guidance of $250-$270 million, compared to the consensus revenue estimate of $313.20 million.

What is Daniel Chard's approval rating as Medifast's CEO?

44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM).

What is Medifast's stock symbol?

Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED."

Who are Medifast's major shareholders?

Medifast's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.45%), Renaissance Technologies LLC (5.98%), State Street Corp (3.49%), Dimensional Fund Advisors LP (3.06%), Principal Financial Group Inc. (2.05%) and Geode Capital Management LLC (2.03%). Insiders that own company stock include Andrea B Thomas, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Jeffrey J Brown, Kevin G Byrnes, Michael C Macdonald and Scott Schlackman.
View institutional ownership trends
.

How do I buy shares of Medifast?

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Medifast's stock price today?

One share of MED stock can currently be purchased for approximately $83.68.

How much money does Medifast make?

Medifast (NYSE:MED) has a market capitalization of $911.02 million and generates $1.53 billion in revenue each year. The specialty retailer earns $143.57 million in net income (profit) each year or $12.77 on an earnings per share basis.

How many employees does Medifast have?

The company employs 984 workers across the globe.

How can I contact Medifast?

Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The official website for the company is www.medifast1.com. The specialty retailer can be reached via phone at (410) 581-8042, via email at ir@choosemedifast.com, or via fax at 410-581-8070.

This page (NYSE:MED) was last updated on 6/3/2023 by MarketBeat.com Staff

My Account -